↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$6KSold on the market
1Companies
Sep 28, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28, 202617:15 | Sep 14, 2026 | LXEOLexeo Therapeutics, Inc. | Chief Operating Officer | A · GrantLate 14d | $2.64 | +2,110 | 138,288 | +2% | $6K | ||
| Aug 19, 202617:00 | Aug 18, 2026 | LXEOLexeo Therapeutics, Inc. | Chief Operating Officer | S · Sell | $4.96 | −1,304 | 136,178 | -1% | −$6K |